In COVID-19 patients, hyperglycemia at admission resulted in hypercoagulability, reflected by elevated D-dimer levels, and a heightened systemic inflammatory response, as evidenced by increased ESR, CRP, and ferritin levels [19,20,21,22,23,24,25]. This evidence concerns the gene ESR1 and COVID-19.